This expert group consensus statement emphasises the need for standardising the definition
of progressive fibrosing interstitial lung diseases (F-ILDs), with an accurate initial diagnosis …

The widespread use of smartphones and the internet has enabled self-monitoring and more
hybrid-care models. The COVID-19 pandemic has further accelerated remote monitoring, …

Background While the high burden of multidrug-resistant tuberculosis (MDR-TB) itself is a
matter of great concern, the emergence and rise of advanced forms of drug-resistance such as …

Recent clinical practice guidelines have addressed the diagnosis of idiopathic pulmonary
fibrosis (IPF) and fibrotic hypersensitivity pneumonitis (fHP). These disease-specific guidelines …

Background: When considering the diagnosis of idiopathic pulmonary fibrosis (IPF),
experienced clinicians integrate clinical features that help to differentiate IPF from other fibrosing …

One view of sarcoidosis is that the term covers many different diseases. However, no
classification framework exists for the future exploration of pathogenetic pathways, genetic or …

The Global Initiative for Asthma (GINA) recently released their updated Global Strategy for
Asthma Management and Prevention Guide (2019). The pocket guide for practicing clinicians …

Coronavirus disease 19 (COVID-19), caused by the severe acute respiratory syndrome-virus
2 (SARS-CoV-2), is a multisystem disease, but the lungs are the primary target of infection …

Introduction Mycophenolate mofetil (MMF), initially approved to prevent rejection in solid organ
allograft, is now being increasingly used for other conditions. Over the last decade, MMF …

Electronic cigarettes use or vaping is popular but has not been proven to be an innocuous
substitute for traditional smoking. Several patterns of vaping-associated lung injuries have …